Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014 - PubMed (original) (raw)
. 2016 Jan 1;64(50-51):1378-82.
doi: 10.15585/mmwr.mm6450a3.
Affiliations
- PMID: 26720857
- DOI: 10.15585/mmwr.mm6450a3
Free article
Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014
Rose A Rudd et al. MMWR Morb Mortal Wkly Rep. 2016.
Free article
Abstract
The United States is experiencing an epidemic of drug overdose (poisoning) deaths. Since 2000, the rate of deaths from drug overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). CDC analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths, including the types of opioids associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1-year increase of 6.5%, from 13.8 per 100,000 persons in 2013 to 14.7 per 100,000 persons in 2014. The rate of drug overdose deaths increased significantly for both sexes, persons aged 25-44 years and ≥55 years, non-Hispanic whites and non-Hispanic blacks, and in the Northeastern, Midwestern, and Southern regions of the United States. Rates of opioid overdose deaths also increased significantly, from 7.9 per 100,000 in 2013 to 9.0 per 100,000 in 2014, a 14% increase. Historically, CDC has programmatically characterized all opioid pain reliever deaths (natural and semisynthetic opioids, methadone, and other synthetic opioids) as "prescription" opioid overdoses (1). Between 2013 and 2014, the age-adjusted rate of death involving methadone remained unchanged; however, the age-adjusted rate of death involving natural and semisynthetic opioid pain relievers, heroin, and synthetic opioids, other than methadone (e.g., fentanyl) increased 9%, 26%, and 80%, respectively. The sharp increase in deaths involving synthetic opioids, other than methadone, in 2014 coincided with law enforcement reports of increased availability of illicitly manufactured fentanyl, a synthetic opioid; however, illicitly manufactured fentanyl cannot be distinguished from prescription fentanyl in death certificate data. These findings indicate that the opioid overdose epidemic is worsening. There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl.
Similar articles
- Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.
Seth P, Scholl L, Rudd RA, Bacon S. Seth P, et al. MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358. doi: 10.15585/mmwr.mm6712a1. MMWR Morb Mortal Wkly Rep. 2018. PMID: 29596405 Free PMC article. - Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.
Rudd RA, Seth P, David F, Scholl L. Rudd RA, et al. MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1. MMWR Morb Mortal Wkly Rep. 2016. PMID: 28033313 - Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Scholl L, et al. MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1. MMWR Morb Mortal Wkly Rep. 2018. PMID: 30605448 Free PMC article. - Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L, Singh VM, Staats PS, Trescot AM, Prunskis J, Knezevic NN, Soin A, Kaye AD, Atluri S, Boswell MV, Abd-Elsayed A, Hirsch JA. Manchikanti L, et al. Pain Physician. 2022 Mar;25(2):97-124. Pain Physician. 2022. PMID: 35322965 Review. - The Opioid Crisis: Prevalence and Markets of Opioids.
Gardner EA, McGrath SA, Dowling D, Bai D. Gardner EA, et al. Forensic Sci Rev. 2022 Jan;34(1):43-70. Forensic Sci Rev. 2022. PMID: 35105535 Review.
Cited by
- Use of Opioid Agonist Therapy for Medicare Patients in 2013.
Lembke A, Chen JH. Lembke A, et al. JAMA Psychiatry. 2016 Sep 1;73(9):990-2. doi: 10.1001/jamapsychiatry.2016.1390. JAMA Psychiatry. 2016. PMID: 27438334 Free PMC article. No abstract available. - Transversus abdominus plane blocks do not reduce rates of postoperative prolonged opioid use following abdominally based autologous breast reconstruction: a nationwide longitudinal analysis.
Chattopadhyay A, Shah JK, Yesantharao P, Ho VT, Sheckter CC, Nazerali R. Chattopadhyay A, et al. Eur J Plast Surg. 2023;46(2):203-213. doi: 10.1007/s00238-022-01996-5. Epub 2022 Oct 4. Eur J Plast Surg. 2023. PMID: 36212234 Free PMC article. - A Randomized Trial Testing the Effect of Narrative Vignettes Versus Guideline Summaries on Provider Response to a Professional Organization Clinical Policy for Safe Opioid Prescribing.
Meisel ZF, Metlay JP, Sinnenberg L, Kilaru AS, Grossestreuer A, Barg FK, Shofer FS, Rhodes KV, Perrone J. Meisel ZF, et al. Ann Emerg Med. 2016 Dec;68(6):719-728. doi: 10.1016/j.annemergmed.2016.03.007. Epub 2016 Apr 29. Ann Emerg Med. 2016. PMID: 27133392 Free PMC article. Clinical Trial. - Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.
Lim JK, Bratberg JP, Davis CS, Green TC, Walley AY. Lim JK, et al. J Addict Med. 2016 Sep-Oct;10(5):300-8. doi: 10.1097/ADM.0000000000000223. J Addict Med. 2016. PMID: 27261669 Free PMC article. Review. - Hospital Prescribing of Opioids to Medicare Beneficiaries.
Jena AB, Goldman D, Karaca-Mandic P. Jena AB, et al. JAMA Intern Med. 2016 Jul 1;176(7):990-7. doi: 10.1001/jamainternmed.2016.2737. JAMA Intern Med. 2016. PMID: 27294595 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources